More about

Ctla-4 Antigen

Clinical Guidance
Immuno-Oncology
Overview

Immune System Signaling Pathways

Jennifer L. Ersek, PhD, MSPH; David M. Foureau, PhD; Edward S. Kim, MD, MBA, FACP, FASCO

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News
February 06, 2023
4 min watch
Save

VIDEO: Botensilimab, balstilimab combination ‘huge innovation’ in colorectal cancer subset

VIDEO: Botensilimab, balstilimab combination ‘huge innovation’ in colorectal cancer subset

In a video interview with Healio, Benjamin Schlechter, MD, of Dana-Farber Cancer Institute, spoke about “the first combination to show efficacy in colorectal cancer in a specialized population.”

News
September 09, 2019
3 min read
Save

First-line durvalumab plus chemotherapy improves OS in extensive-stage small cell lung cancer

First-line durvalumab plus chemotherapy improves OS in extensive-stage small cell lung cancer

BARCELONA — The addition of durvalumab to platinum-etoposide chemotherapy significantly extended OS among patients with extensive-stage small cell lung cancer, according to results of the CASPIAN study presented at International Association for the Study of Lung Cancer World Conference on Lung Cancer.